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Dysregulations of mitochondria with alterations in trafficking and morphology of these organelles have been related to Parkinson’s
disease (PD), a neurodegenerative disorder characterized by brain accumulation of Lewy bodies (LB), intraneuronal inclusions
mainly composed of α-synuclein (α-syn) fibrils. Experimental evidence supports that α-syn pathological aggregation can
negatively impinge on mitochondrial functions suggesting that this protein may be crucially involved in the control of
mitochondrial homeostasis. The aim of this study was to assay this hypothesis by analyzing mitochondrial function and
morphology in primary cortical neurons from C57BL/6JOlaHsd α-syn null and C57BL/6J wild-type (wt) mice. Primary cortical
neurons from mice lacking α-syn showed decreased respiration capacity measured with a Seahorse XFe24 Extracellular Flux
Analyzer. In addition, morphological Airyscan superresolution microscopy showed the presence of fragmented mitochondria
while real-time PCR and western blot confirmed altered expression of proteins involved in mitochondrial shape
modifications in the primary cortical neurons of α-syn null mice. Transmission electron microscopy (TEM) studies showed
that α-syn null neurons exhibited impaired mitochondria-endoplasmic reticulum (ER) physical interaction. Specifically, we
identified a decreased number of mitochondria-ER contacts (MERCs) paralleled by a significant increase in ER-mitochondria
distance (i.e., MERC length). These findings support that α-syn physiologically preserves mitochondrial functions and
homeostasis. Studying α-syn/mitochondria interplay in health and disease is thus pivotal for understanding their involvement
in PD and other LB disorders.
1. Introduction
The pathological aggregation of α-synuclein (α-syn) and
its deposition in proteinaceous inclusions named Lewy
bodies (LB) is the key pathological hallmark of LB disorders
such as Parkinson’s disease (PD). This is the most common
neurodegenerative movement syndrome and is character-
ized by a progressive loss of dopaminergic neurons of the
nigrostriatal system.
The aggregation of pathological α-syn is thought to be the
major agent of PD pathophysiology [1], but mitochondrial
deficits have been largely described as crucial pathogenic
events in the pathogenesis of PD [2]. Indeed, a bidirectional
interplay between α-syn and mitochondrial dysfunction has
been described, since α-syn aggregatesmay negatively impinge
on mitochondrial homeostasis and dynamics, while mito-
chondrial dysfunctions severely affect α-syn deposition [3].
It has been reported that a fraction of soluble α-syn
directly interacts with mitochondria-associated endoplas-
mic reticulum (ER) membranes (MAM) [4], influencing
mitochondrial fusion and fission. Interestingly, α-syn aggre-
gation produces mitochondrial fragmentation or mitochon-
drial respiration failure and death in cell-based models of
PD [5–7]. Furthermore, mitochondrial protein import and
protein degradation may impact on α-syn and mitochondrial
physiological functions, but their reciprocal modulation is
still to be elucidated [8]. On the other hand, a protective role
of α-syn was identified in neurons exposed to oxidative stress
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[9], while the effect of several neurotoxins on mitochondria
deficiency is thought to be mediated, at least in part, by α-
syn aggregation [3, 10]. For instance, elevated levels of α-
syn promote the toxic action of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), which inhibits mitochondrial
complex I [11], that is deficient in PD brains [12, 13]. Con-
trariwise, α-syn-deficient mice exposed to rotenone exhibited
a pronounced degeneration of dopamine neurons exceeding
that observed in wild type (wt) mice [14], even if silencing
α-syn was reported to prevent neuron degeneration in an
in vitro model [15]. These findings fit with the hypothesis
that alterations of α-syn may contribute to bioenergetics
defects inducing mitochondrial dysfunctions and PD onset.
This notwithstanding, α-syn deficiency per semay also nega-
tively impinge on mitochondrial homeostasis [16], support-
ing that the metabolism and function of healthy neurons
may depend on the expression levels and conformation of
α-syn and on the critical interplay between α-syn and mito-
chondria, with imbalances in their reciprocal modulation
leading to neuronal impairment [3].
The aim of this study was to assay the relevance of α-syn
function on mitochondrial homeostasis by assessing whether
primary cortical neurons, produced from C57BL/6JOlaHsd
mice carrying a spontaneous deletion of α-syn locus (α-syn
null) [17], may present alterations of mitochondrial function
and morphology when compared to those of C57BL/6J wt
animals.
The Oxygen Consumption Rate (OCR) of cortical neu-
rons from wt or α-syn null mice was evaluated by a
Seahorse-based analysis both in basal condition and after
exposure to the Complex I inhibitor rotenone. Mitochondria
morphology was studied by using both Airyscan superre-
solution microscopy on mito-YFP-transfected neurons and
transmission electron microscopy (TEM). Finally, the
expression of proteins mediating mitochondria fusion and
fission was also evaluated by real-time polymerase chain
reaction (PCR) and western blotting (WB). These studies
revealed a reduced mitochondrial respiration of α-syn null
neurons and an increased susceptibility to rotenone adminis-
tration. These cells also exhibited an increased mitochondrial
fragmentation and alterations in the key proteins mediat-
ing mitochondrial fission and fusion, such as mitofusin
(Mfn1) and the dynamin-like GTPase Opa1. Finally, TEM
studies showed that the primary cortical neurons from α-
syn null mice exhibited a decreased number of mitochon-
dria-ER contacts (MERCs) and a significant increase in
ER-mitochondria distance.
Our findings strongly support that, by orchestrating
mitochondrial fusion and functions and preserving MERCs,
α-syn physiologically acts as a determining regulator of mito-
chondrial homeostasis.
2. Materials and Methods
2.1. Animals. C57BL/6J wt (Charles River, Wilmington, MA)
and C57BL/6JOlaHsd (Harlan Olac Bicester, UK) mice were
bred in our animal house facility at the Department of
Molecular and Translational Medicine of University of Bre-
scia, Brescia, Italy. Animals were maintained under a 12 h
light-dark cycle at a room temperature (rt) of 22°C and had
ad libitum food and water. All experiments were made
in accordance to Directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010 on
the protection of animals used. All experimental and surgical
procedures for the preparation of primary cortical neuronal
cell cultures from 18-day embryos were conformed to the
National Research Guide for the Care and Use of Laboratory
Animals and were approved by the Animal Research Com-
mittees of the University of Brescia (Protocol Permit
719/2015-PR). All achievements were made to minimize ani-
mal suffering and to reduce the number of animals used.
2.2. Primary Cortical Neurons. Primary cortical neurons were
dissected from C57BL/6J wt control mice and C57BL/6JO-
laHsd α-syn null mice, carrying a spontaneous deletion
of the α-syn locus [17], at embryonic day 18 according to pre-
viously described protocols [18]. After dissociation with
Accumax (Sigma-Aldrich, Milan, Italy), the single cells were
resuspended in a Neurobasal medium (Thermo Fisher Sci-
entific, Massachusetts, USA) containing 100μg/ml penicil-
lin, 100μg/ml streptomycin (Sigma-Aldrich, Milan, Italy),
2mM glutamine (EuroClone, Milan, Italy), and 1% B27 sup-
plement (Thermo Fisher Scientific) and then centrifuged.
Cell counts and viability assays were performed using the
Trypan Blue exclusion test. Neurons were seeded onto glass
coverslides in 24-well plates for imaging analyses, Seahorse
XFe24-well plates for energetic analyses, 24-well plates for
TEM analyses or Petri dishes coated with 10-12μg/ml poly-
D-lysine for quantitative analyses. Cells were maintained at
37°C under a humidified atmosphere of 5% CO2 in the Neu-
robasal medium for 8-10 days in vitro (DIV).
2.3. Cortical Neuron Respirometry Analysis. Seahorse XF
Cell Culture Microplates (Seahorse Biosciences, Agilent
Technologies, USA) were used to seed 45,000 cortical neu-
rons per well. At day 8, cells were treated with 100 nM rote-
none, which was directly added in the cell culture media for
1 h and analyzed the following day. The medium was
replaced with freshly prepared Seahorse XF Base Media
(25mM glucose, 0.25mM sodium pyruvate, and 1mM L-
glutamine, pH 7.4) in a non-CO2 incubator for 1 h prior to
the assay, then loaded on a Seahorse XF24 Extracellular Flux
Analyzer (Seahorse Biosciences). The XF Cell Mito Stress
Test (Agilent technologies) was performed, after 3 cycles of
basal condition, sequentially injecting 1μM oligomycin,
0.5μM carbonyl cyanide-4-(trifluoromethoxy)phenylhydra-
zone (FCCP), and 0.5μM rotenone plus 0.5μM antimycin
A. Oxygen Consumption Rate and Extracellular Acidifica-
tion Rate (ECAR) were measured every three cycles of
3min mix after the injection.
Normalization was performed by using the Bio-Rad DC™
protein assay kit (Bio-Rad Laboratories, California, USA).
Basal respiration was measured as the last rate before the
first injection minus the nonmitochondrial respiration rate
deriving from the rotenone/antimycin injection. Maximal
respiration was considered the maximum rate measurement
after the FCCP injection minus the nonmitochondrial respi-
ration rate. The ATP-linked respiration was calculated as the
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subtraction of the last measurement before oligomycin injec-
tion and the minimum rate after oligomycin injection.
2.4. Mitochondrial Isolation and Seahorse Analysis. Liver,
cortex, and midbrain tissues were explanted from two-
month-old mice after cervical dislocation. After five washes
with MIB1 buffer (210mM D-mannitol, 70mM sucrose,
5mM HEPES, 1mM EGTA and 0.5% free fatty acid BSA),
tissues were homogenate and centrifuged at 600g for 10min
at 4°C. The supernatant was then centrifuged at 7000g for
10min at 4°C. After washing the pellet with MIB1 by centri-
fugation at 7000g for 10min at 4°C, the pellet was resus-
pended in MAS1 (220mM D-mannitol, 70mM sucrose,
2mM HEPES, 1mM EGTA, 0.2% free fatty acid BSA,
10mM KH2PO4, 5mM MgCl2, 10mM glutamate, 5mM
malate, and 10mM succinate, pH 7.2).
The total mitochondrial extract was quantified by using
the Bio-Rad DC™ protein assay kit and 7μg per well was
loaded in the 24-well Seahorse plate and centrifuged at
600g for 20min at 4°C.
The XF Cell Mito Stress Test was performed, after one
cycle of basal condition, sequentially injecting 4mM ADP,
2.5μg/ml oligomycin, 4μM FCCP, and 4μM rotenone plus
4μM antimycin A.
Basal respiration was measured as the first basal rate
minus the nonmitochondrial respiration rate deriving from
the rotenone/antimycin injection. State III was calculated as
the measurement after the ATP injection minus the nonmi-
tochondrial respiration rate, State IV0 as the measurement
after oligomycin minus the last rate, and State IIIu as the
measurement after FCCP injection minus the last rate.
2.5. Mito-Yellow Fluorescent Protein (YFP) Transfection and
Immunofluorescence Staining. For imaging analysis, 80,000
primary cortical neurons were seeded onto poly-D-lysine-
coated glass coverslides in 24-well plates. At 8 days of differ-
entiation, neurons were transfected with pEYFP-Mito (Cata-
log #6115-1, Clontech) by using Lipofectamine 3000 (Life
Technologies, California, USA), according to the manufac-
turer’s instructions.
Fixed neurons were permeabilized in PBS 0.1M supple-
mented with 20% methanol and 0.1% Triton X-100, incu-
bated for 1 h at rt in blocking solution (2% Normal Goat
Serum (NGS), 3% Bovine Serum Albumin (BSA), and 0.1%
Triton-X100 in PBS 0.1M), and then with the primary anti-
body (Microtubule-Associated Protein 2 (MAP-2), Merck
Millipore, Burlington, Massachusetts, USA) in blocking solu-
tion overnight at 4°C. Neurons were washed with 0.1% Triton
X-100 PBS 0.1M and incubated with the fluorochrome-
conjugated secondary antibody (goat anti-mouse cy3, Jack-
son ImmunoResearch, Cambridge, UK) in 0.1% Triton
X-100 PBS 0.1M plus 1mg/ml BSA for 1 h at rt. After three
washes in 0.1% Triton X-100 PBS, cells were mounted onto
superfrost slides using a VECTASHIELD mounting medium
for fluorescence (Vector Laboratories, Burlingame, CA) and
observed by means of a Zeiss confocal laser microscope
LSM 880 (Carl Zeiss, Oberkochen, Germany) with Airyscan
superresolution and z-stack with the height of the sections
scanning ≅ 1 μm. Images (1024 × 1024 pixels) were then
reconstructed using Zen lite 2.3 (Carl Zeiss).
2.6. Quantification of Mitochondrial Morphology. The num-
ber of mitochondria and the total area of mitochondria per
neuron were analyzed by using the macro of ImageJ Soft-
ware designed by Dagda et al. [19] with minor modification
to differentially analyze cell bodies and dendrites. All the
z-stack images were processed to maximum intensity projec-
tion. The acquisition parameters during confocal imaging
were maintained constant for all the image settings used for
the analysis.
The interconnectivity between mitochondria was ana-
lyzed using the mitochondrial network analysis (MiNA)
toolset [20].
2.7. Real-Time PCR. Total RNA was extracted from wt
and α-syn null cortical neurons using an RNA extraction
kit (RNeasy Mini Kit, Qiagen, Hilden, GE) according to
the manufacturer’s recommendations. Two micrograms of
RNA was retrotranscribed by using a QuantiTect Reverse
Transcription Kit (Qiagen) according to the manufacturer’s
instructions. Real-time PCR was performed by using a SYBR
Green Master Mix (Applied Biosystems, Foster City, USA)
and the following primer pairs: Mfn1 for ACAAGCTTGCT
GTCATTGGG Mfn1 rev TCGACACTCAGGAAGCAGTT;
Mfn2 for ATATAGAGGAAGGTCTGGGCCG, Mfn2 rev
CCGCATAGATACAGGAAGAAGGG; Opa1 rev GTCATT
GTCGGAGCAGGAATC, Opa1 for TTCACTAAGGATTG
GCAGACTT; and GAPDH for TCAACAGCAACTCCAC
TCTT, GAPDH rev CCAGGGTTTCTTACTTACTCCTTGG.
The ViiA7 Real-Time PCR system (Life Technologies,
Grand Island, NY, USA) was used for 40 cycles of 95°C for
15 s and 60°C for 1min. mRNA expression was normalized
to glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
gene expression.
2.8. Western Blot Analysis. Total proteins were extracted with
a Radioimmunoprecipitation Assay (RIPA) buffer made up
with 50mM Tris-HCl pH 7.4, 150mM NaCl, NP-40 1%,
sodium deoxycholate 0.1%, sodium dodecyl sulfate (SDS)
0.1%, 1mM NaF, and 1mM NaVO4 plus complete prote-
ase inhibitor mixture (Roche Diagnostics, Mannheim, Ger-
many). Protein concentration in the samples was measured
by using the Bio-Rad protein assay kit. Equal amounts of
proteins (30μg) were run on 10% polyacrylamide gels and
transferred onto polyvinylidene fluoride (PVDF) membrane.
Densitometric analysis of the bands was performed by using
ImageJ software and all bands were normalized to Tom20
levels as a control of equal loading of samples in the total pro-
tein extracts. For densitometry analysis of bands, each exper-
imental condition was performed in quadruplicate and the
resulting data were subjected to statistical analysis. The pri-
mary antibodies used for western blot analysis were the fol-
lowing: Opa1 (1 : 1000; Abcam; ab42364), Mfn2 (1 : 1000;
Abnova; H00009927-M03) and Tom20 (1 : 1000; Santa Cruz;
sc-11415). Secondary antibodies used were sheep anti-mouse
or donkey anti-rabbit HRP (GE Healthcare, Chicago, USA).
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2.9. Transmission Electron Microscopy Ultrastructural
Morphological Analysis. For ultrastructural morphological
analysis, cortical neurons were fixed with Immunofix (BioOp-
tica, Milan, Italy) for 1 hour. After rinsing in 0.1M cacodylate
buffer with 1% tannic acid, samples were postfixed in 1 : 1 2%
OsO4 and 0.2M cacodylate buffer for 1 h. Samples were
rinsed, dehydrated in ethanol and embedded in Epon resin.
Ultrathin sections were imaged on a Tecnai-20 electron
microscope (Philips-FEI).
2.10. Analysis of TEM Mitochondria-ER Contacts. The
number of mitochondria-ER contacts has been analysed
for ultrastructure in a minimum of 250 contacts per condi-
tion. Morphometric measurements were carried out using
ImageJ. For calculations of the mitochondria-ER distance,
n > 5 mitochondria per image in 60 images per condition
were considered and a minimum distance of ER located
in a 40 or 10 nm radius from the considered mitochondria
was computed.
3. Results and Discussion
The aggregation of α-syn has been repeatedly associated
with mitochondrial dysfunctions [16], but the physiologi-
cal role of α-syn in mitochondrial function still needs to
be elucidated in order to achieve extensive comprehension
of α-syn/mitochondria interplay.
To probe whether α-syn can physiologically influence
mitochondrial function, we examined both mitochondrial
respiration and morphology in primary cortical neurons
derived from C57BL/6J wt and C57BL6JOlaHsd α-syn
null mice.
In particular, mitochondrial respiration of murine pri-
mary cortical neurons of wt and α-syn null mice was
analyzed by using the Seahorse XFe24 Extracellular Flux
Analyzer measuring the OCR and the ECAR (Figure 1(a)).
The ATP synthase inhibitor oligomycin, the mitochondrial
oxidative phosphorylation uncoupler FCCP and the Com-
plex I inhibitor rotenone plus the complex III inhibitor
antimycin A were sequentially injected to evaluate basal
respiration, ATP production and maximal respiration of
primary neuronal cells.
Interestingly, we found that α-syn null neurons exhibited
a significant decrease in basal respiration when compared
to that of wt control cells. Maximal respiration (i.e., mito-
chondrial energetic reserve capability) and ATP produc-
tion were also reduced in the cortical neurons lacking α-syn
(Figure 1(b)). These findings support that the absence of α-
syn compromises the OCR both in basal conditions and in
response to FCCP, which, by stimulating the respiratory
chain to run at maximum capacity, allows estimating the
energetic reserve capability of the cell.
By analyzing OCR, we also found that the α-syn null neu-
rons, which were subjected to 1 h rotenone pretreatment,
exhibited a significant decrease in basal respiration, maximal
respiration and ATP production after the 24 h washout,
when compared to untreated α-syn null neurons. This find-
ing is in line with evidence supporting that α-syn-deficient
mice are more sensitive to rotenone and show amore marked
degeneration of dopaminergic neurons upon exposure to this
neurotoxin (Dauer et al., PNAS, 2002). Conversely, the OCR
profile of wt neurons was not affected by 1h rotenone pre-
treatment, supporting that these cells displayed a better resil-
ience within our experimental paradigm. This observation
supports that in α-syn null neurons, the functional activity
of mitochondria resulted in more vulnerability to the 1 h
Complex I inhibition achieved by rotenone pretreatment.
We examined the ECAR profile, an indirect but reliable
index of cellular glycolytic rate [21], in basal conditions and
in response to mitochondrial respiratory chain inhibitors in
wt and α-syn null neurons (Figure 1(a)). We found that the
absence of α-syn reduced the basal and oligomycin-
stimulated ECAR profile when compared to that of wt neu-
rons, regardless of rotenone pretreatment.
While rotenone is known to inhibit neuronal OCR and
enhance ECAR when measured during its infusion [22], we
found that 1 h rotenone pretreatment per se did not affect
ECAR and OCR in wt neuronal cells. This could be explained
by the recovery of neuronal bioenergetic capacity during the
24 h washout period. The combined evaluation of the OCR
and ECAR parameters in basal conditions, as shown in the
energy map (Figure 1(a)), indicated that wt neurons have
higher bioenergetics capacity, whereas α-syn null neurons
have a more quiescent metabolic phenotype.
Finally, we analyzed mitochondrial OCR also in mito-
chondria purified from liver, cortices, and midbrain of adult
wt and α-syn null mice, but we did not detect any difference
in respiration or ATP production (Figures 1(c) and 1(d)).
This may possibly be ascribed to the fact that α-syn is
enriched in neurons. Therefore, α-syn absence would not
affect mitochondrial respiration in peripheral tissues and
its effect may be hardly detectable in brain mitochondrial
preparations due to the presence of mitochondria deriving
from glial cells, which do not normally express the protein
[23–25]. Contrariwise, the expression of α-syn in neurons is
elevated, especially at synaptic sites [26], where mitochondria
are also abundant [27]. This supports that α-syn may affect
mitochondrial homeostasis and impinge on respiration
exclusively in neuronal cells.
Collectively, these findings support that α-syn null neu-
rons exhibit a reduced respiration and are also less energetic,
thus supporting that α-syn plays a relevant role in orchestrat-
ing mitochondrial functions and energy production.
It has been found that, in the presence of α-syn aggre-
gates, neurons show fragmented mitochondria [28, 29].
Considering that α-syn aggregation may mimic a loss of
function of the protein [30], we analyzed the morphology
of mitochondria in the MAP-2-immunolabelled cortical
neurons from wt and α-syn null mice which had been trans-
fected with mito-YFP construct (Supplementary Figure 1)
to discriminate mitochondria within the cell soma and
dendrites (Figure 2). These areas were separately examined,
as dendrites were acquired by standard confocal microscopy,
while cell somas were acquired by Airyscan superresolution
microscopy to allow a better visualization of mitochondrial
morphology.
By analyzing the dendrites of α-syn null neurons, we
found a decrease in the number of mitochondria, which also
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exhibited a reduction in the mean area when compared to
those of wt neurons (Figure 2(a)). This is in line with previ-
ous studies showing increased mitochondrial fragmentation
after α-syn silencing in HeLa cells [31]. Moreover, the num-
ber of interconnections between mitochondria, analyzed by
using the MiNA toolset, was also significantly decreased in
α-syn null neurons. The reduction of mitochondrial contacts
and mitochondrial mean area may be indicative of mito-
chondrial fission/reduced fusion [32, 33] occurring in the
absence of α-syn.
Interestingly, when we analyzed mitochondria number
and morphology in the cell bodies, we found that α-syn null
neurons exhibited an increased number of mitochondria,
whose mean area only showed a trend toward size reduction,
which however did not show significant results with respect
to wt cells (Figure 2(b)). Moreover, the absence of α-syn
did not result in a decrease of mitochondria interconnections
in cell bodies. These findings suggest that α-syn null neurons
may present an impairment of mitochondrial transport along
processes, which may show mitochondrial fission as a conse-
quence of this process [34, 35].
Mitochondrial fragmentation may be associated with
changes in the expression of fusion and fission proteins
[35]. While mitochondrial fusion is considered a prosurvival
mechanism [36], fission/fragmentation is often an index of
mitochondria damage.
We thus analyzed the expression levels of genes involved
in mitochondrial shape modifications: Mfn1, Mfn2, Opa1,
and Drp1 (Figure 3(a)). In the cortical neurons of α-syn
null mice, we observed decreased levels of Mfn1, which is
involved in the fusion of the outer mitochondrial membrane,
but no changes in the expression of the fission protein Drp1
or in Opa1 and Mfn2. This finding supports that, by mod-
ulating Mfn1 expression, α-syn may ensure mitochondrial
fusion but does not seem to affect proteins controlling the
fission, stability, or formation of these organelles. This is
in line with evidence indicating that α-syn aggregation
inhibits mitochondrial fusion through a Drp1-independent
pathway [37].
The absence of Mfn2 changes was confirmed by western
blot analysis (Figure 3(b)), which showed an interesting
increase in the ratio between the short and long forms of
Opa1, which is crucially involved in control of mitochondrial
morphology. This observation supports that the absence of
α-syn can promote mitochondrial fission also by reducing
long Opa1, which is relevant for conferring fusion compe-
tences [38]. On the other hand, an increased short Opa1 gen-
eration can promote fragmentation [39].
Since the presence of wt α-syn was previously observed
in MAM [4] and mitofusins are known to be involved in
mediating MERCs [40–42], we also analyzed mitochondria-
ER interactions by TEM (Figure 4). Indeed, Mfn2 is known
to have a key role in the mitochondria-ER tethering but
is also known to form homo- or heterodimerization with
Mfn1. By localizing to MAM [4], α-syn absence could
modify Mfn2 localization, thus consequently influencing
mitochondria-ER interaction. The results of this part of the
study showed a decreased number of MERCs in the α-syn
null neurons when compared to that of wt neurons that still
significantly decreased when normalized on the number
of mitochondria. In parallel, we observed an increased dis-
tance between mitochondria and the ER. MERCs are rele-
vant for ensuring mitochondrial biogenesis, dynamics, and































Figure 1: Seahorse-based mitochondrial respiration assay on primary cortical neurons or mitochondria purified from wt or α-syn null mice.
(a) The two graphs show time-dependent changes in OCR and ECAR measured sequentially injecting oligomycin, FCCP, and rotenone plus
antimycin A on primary cortical neurons of wt and α-syn null mice in basal conditions or after rotenone exposure. Basal OCR and ECAR
values (before oligomycin injection) were plotted in the energy map to illustrate the difference in the cell metabolic profile. (b) Basal
respiration (first injection minus the rotenone/antimycin injection), maximal respiration (rate after the FCCP injection minus the
nonmitochondrial respiration rate), and ATP production (measurement before oligomycin injection and after the oligomycin injection)
showed a decreased respiration of α-syn null cortical neurons that are significantly affected by rotenone treatment. (c) OCR of
mitochondria purified from the liver, cortices, and midbrains was measured sequentially injecting ADP, oligomycin, FCCP, and rotenone
plus antimycin A. Note the absence of changes between C57BL/6J wt and C57BL/6JOlaHsd α-syn null mice. (d) The basal respiration, the
State III, the State IV0, and the State IIIu did not show differences in the OCR of liver, cortex, and midbrain extracts between wt and α-syn
null mice. ∗P < 0:05, ∗∗P < 0:01, and ∗∗∗P < 0:001, two-way ANOVA+Bonferroni’s postcomparison test. Data are presented as mean ±
standard error of themean (SEM) (n = 12).
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mitochondrial function, division, and regulation of apopto-
sis [43]. Our data confirm and extend previous studies
showing alterations in MAM structure due to α-syn muta-
tions [4] and the disruption of ER-mitochondrial contacts
caused by α-syn overexpression [44], which may coincide
with a loss of α-syn function. Further research is required
to assess whether the reduction of MERCs and increased
mitochondria-ER distance observed in the α-syn null mice



























































































Figure 2: Mitochondrial morphology in mito-YFP transfected primary cortical neurons of wt and α-syn null mice. (a) Representative images
of maximum intensity projections of primary cortical neurons from wt and α-syn null mice transfected with mito-YFP construct at 8 DIV.
The morphological analysis showed decreased number of mitochondria exhibiting also reduction in the mean area and in the number of
interconnections in those of α-syn null mice when compared to wt neurons. (b) Maximum intensity projection of Airyscan
superresolution microscopy showed an increased number of mitochondria in the cell body of α-syn null neurons which did not exhibit
reductions in the mean area or in their interconnections when compared to those of wt mice. ∗P < 0:05, unpaired two-tailed t-test. Data
are presented as mean ± SEM (n = 30). Scale bar: a = 50 μm and b = 10μm.
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4. Conclusions
Collectively, the results of this study support that α-syn plays
a physiological and essential role in the control of mitochon-
drial respiration capacity and homeostasis.
Alpha-synuclein aggregation and mitochondrial defects
are believed to be central in the pathogenesis of neurodegen-
eration in PD [3, 10, 45, 46]. This is clearly reinforced by the
fact that mutations of α-syn or mitochondria-associated
genes can cause the onset of familial early-onset parkinson-
ism [47, 48]. Interestingly, recent evidence pointed out that
α-syn localizes in and affects MAM function [4, 16, 49] and
that the N-terminus of α-syn, a region exhibiting high affinity
for biological membranes [50], can control mitochondrial
membrane permeability [51]. Moreover, α-syn can interact
with Complex I modulating its activity [52], while α-syn
overexpression induces mitochondrial fission by interacting
with mitochondrial membranes [5]. The α-syn-mediated
control of mitochondrial homeostasis, which is not altered
by the A30P variant, is selectively disrupted by the A53T
mutation [45]. Consistently, A53T transgenic mice show a
marked reduction of the Na+-Ca2+ exchanger 3 (NCX3)
accompanied by mitochondrial Ca2+ overload, events which
have been proposed to be central for neurodegeneration of
dopaminergic neurons in this mouse line [53]. These studies,
strongly supporting a role for α-syn in mitochondrial
homeostasis, fail to provide information on the physiological
role of α-syn on morpho-functional aspects of mitochon-
drial biology. In line with the Complex I deficit previously
described by Devi and colleagues [52], electron transport
chain impairment, with no changes in mitochondrial num-
ber, has been demonstrated in mice lacking α-syn [54]. Nev-
ertheless, a complete characterization of the physiological
effects of α-syn on mitochondrial morphology and activity
in pure neuronal preparations have never been investigated
before, with the exception of a single study that however failed
to detect differences in mitochondrial bioenergetics between
wt and α-syn ko mice [55].
Remarkably, our results are partially in line with those
described by Pathak et al. as when we analyzed mitochondria
purified by cortical tissues, we also failed to detect functional
differences. Differently from their findings on primary hip-
pocampal neurons prepared from α-syn ko pups, when we
analyzed primary cortical neurons from α-syn null mouse
embryos, we found that they exhibited significant reduction
in basal and maximal respirations as well as ATP production
when compared to those from wt mouse embryos. Moreover,
α-syn null neurons resulted in more vulnerability to rotenone
treatment, supporting that the effect of this toxin is influ-
enced by the presence of α-syn. The functional impairments
were accompanied by marked reduction of MERCs as well as
by mitochondrial morphology alterations supportive of the
occurrence of fragmentations within dendrites and reduction
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Figure 3: Expression levels of mitochondrial proteins involved in shape modification. (a) Relative expression of Mfn1, Mfn2, Opa1, and Drp1
was evaluated by using real-time PCR on primary cortical neuron extracts of wt and α-syn null mice. Note the statistically significant
reduction of Mfn1 in the primary cortical neurons from α-syn null mice. (b) Western blot analysis revealed increased ratio between the
short and long forms of Opa1 in the absence of α-syn which did not exhibit alterations in the levels of Mfn2. ∗P < 0:05, unpaired two-
tailed t-test. Data are presented as mean ± SEM (n = 8).
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syn can vary between diverse brain areas and different
neuronal populations [56], thus supporting that the pro-
tein may differentially impinge on mitochondrial functions
in hippocampal or cortical neurons. Therefore, the discrep-
ancies between our findings and those described by Pathak
et al. can be the result of different factors: (a) we analyzed dif-
ferent neuronal subpopulations (whole cortices vs. hippo-
campi); (b) these were prepared at different time points
(embryos vs. pups); and (c) we used different strains and
experimental models (C57BL/6J α-syn null vs. C57BL/6N
α-syn ko mice).
Notably, our results sound in agreement with multiple
evidence supporting that α-syn overexpression and muta-
tions can influence mitochondrial homeostasis and fragmen-
tation as well as ER-mitochondrial interaction [4, 5, 46, 52].
However, the physiological effect α-syn on mitochondria
function, morphology, and interaction with ER had been
only partially addressed up to date [4, 5, 37, 57]. Our results
support that α-syn can physiologically affect the mitochon-
drial functional profile, preserves mitochondrial fusion and
transport, and contributes to ensure MERCs in neuronal
cells. When considering the central role that α-syn aggrega-
tion plays in PD, these observations support that the absence
of the protein in C57BL/6JOlaHsd null neurons may mimic
the effects derived from α-syn insoluble inclusion formation,
which, by sequestering the protein, may reduce its functional
profile [3, 30, 46]. This process may severely alter mitochon-
drial and mitochondria/ER dynamics, thus promoting neu-
ronal damage and degeneration.
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Figure 4: TEM-based morphological analysis of mitochondria-ER interaction of primary cortical neurons of wt and α-syn null mice. (a)
Representative images of TEM showing the mitochondria-ER interactions in primary cortical neurons of wt and α-syn null mice.
ER= endoplasmic reticulum; M=mitochondria. Scale bar: 500 nm. (b) The image analysis showed an increased distance between
mitochondria and ER, a decreased number of MERCs, and a decreased ratio in the number of contacts per mitochondria in α-syn null
neurons when compared to wt neurons. ∗P < 0:05 and ∗∗P < 0:01, unpaired two-tailed t-test. Data are presented as mean ± SEM (n = 5).
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Supplementary Materials
Supplementary Figure 1: representative photomicrographs
showing MAP-2-labelled neurons transfected with mito-
YFP construct of wt and α-syn null mice. Scale bar: 20μm.
(Supplementary Materials)
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